ASCO GUIDELINES Bundle - Noncastrate Advanced, Recurrent or Metastatic Prostate Cancer Initial Management
Advances in Prostate Cancer Chemotherapy: A New Era Begins1 - Pienta - 2005 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment Decisions | American Society of Clinical Oncology Educational Book
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial - The Lancet
Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer—Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial - ScienceDirect
Cancers | Free Full-Text | Administering Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 1–6 Days Compared to More Than 14 Days after the Start of LHRH Agonist Is Associated with Better Clinical Outcomes
Advanced Prostate Cancer: AUA/SUO Guideline - American Urological Association
Prostate Cancer News, Reviews & Views: May 2021
Sequencing of Systemic Therapies in the Management of Advanced Prostate Cancer in India: a Delphi-Based Consensus | Oncology and Therapy
Salvage therapy for prostate cancer after radical prostatectomy | Nature Reviews Urology
Multimodal Primary Treatment of Metastatic Prostate Cancer with Androgen Deprivation and Radiation | Anticancer Research
Treatment of Castration-Resistant Prostate Cancer (CRPC)
Modern treatment of metastatic prostate cancer | Tidsskrift for Den norske legeforening
ASTRO 2021: NCCN Guidelines for Radiation Therapy and Prostate Cancer: Updates and Controversies
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer - ScienceDirect
Frontiers | Prostate Cancer Theranostics - An Overview
Trial profile for Scandinavian Prostate Cancer Group 12: Arm A adjuvant... | Download Scientific Diagram
Full article: Docetaxel radiosensitizes castration-resistant prostate cancer by downregulating CAV-1
Diagnostics | Free Full-Text | Diagnostic Strategies for Treatment Selection in Advanced Prostate Cancer
ASTRO 2021: NCCN Guidelines for Radiation Therapy and Prostate Cancer: Updates and Controversies
How to Treat Prostate Cancer With Androgen Deprivation and Minimize Cardiovascular Risk: A Therapeutic Tightrope | JACC: CardioOncology
Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer | Prostate Cancer and Prostatic Diseases
Current Oncology | Free Full-Text | A Real-World Evidence Study Using Alberta-Population-Based Data to Describe Treatment Patterns for Metastatic Castration-Sensitive Prostate Cancer Patients (AWARENESS)
Prostate Cancer - INTRODUCTION - Uroweb
